RT Journal Article
SR Electronic
T1 Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.10.20246991
DO 10.1101/2020.12.10.20246991
A1 Ahmadi, Mohsen
A1 Mousavi, Pegah
A1 Saffarzadeh, Negin
A1 Hajiesmaeili, Fatemeh
A1 Habibipour, Leila
YR 2020
UL http://medrxiv.org/content/early/2020/12/11/2020.12.10.20246991.abstract
AB Hypoxanthine phosphoribosyl transferase (HPRT1), as a salvage pathway enzyme, plays a crucial role in modulating the cell cycle and has been reported to be overexpressed in multiple cancers. Nevertheless, the relationship between the HPRT1 and Head and Neck Squamous Cell Carcinomas (HNSCC) has not been investigated so far. We first evaluated the expression of HPRT1 at transcriptomic and proteomic levels in tumor and healthy control tissues and its clinical value using The Cancer Genome Atlas (TCGA), Human Protein Atlas, Kaplan-Meier Plotter databases, GSE107591, and quantitative real-time PCR analysis. Then, we employed the COSMIC and cBioPortal databases to assess the mutations of the HPRT1 gene and their association with survival outcomes of patients with HNSCC. Finally, we performed the functional enrichment analysis for HPRT1 co-expressed genes in HNSCC utilizing the Enrichr database. The mRNA and protein expressions of HPRT1 were significantly elevated in HNSCC compared with normal tissues. Besides, the upregulation of HPRT1 expression was correlated with age, sex, pathological stage, and histological grades of HNSCC patients. Moreover, the increased expression of HPRT1 in cancer tissues exhibited a strong capacity for being a promising biomarker for the diagnosis and prognosis of patients with HNSCC. The co-expressed genes of HPRT1 were mainly enriched in several cancer-related processes such as DNA replication and cell cycle. The present study demonstrated that the overexpression of HPRT1 is significantly correlated with the progression of HNSCC and may serve as a useful biomarker for the early detection and risk stratification of patients with HNSCC.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by Hormozgan University of Medical Sciences and Booali Medical Diagnostic Laboratory.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of Hormozgan University of Medical Sciences. Written informed consent was signed by all patients before involvement in this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data of TCGA were obtained from the website of university of California Santa Cruz (UCSC) Xena browser (https ://xenab rowser.net/). The data of the GSE107591 dataset were downloaded from the website of the GEO database (https://www.ncbi.nlm.nih.gov/geo/). The data of the validation cohort used for this research are available from the corresponding author upon request.AUCArea Under the ROC CurveBPBiological ProcessesCCCellular ComponentCOSMICCatalogue of Somatic Mutations in CancerGEOGene Expression OmnibusGOGene OntologyHNSCCHead and Neck Squamous Cell CarcinomasHPAHuman Protein AtlasHPRT1Hypoxanthine phosphoribosyl transferaseKEGGKyoto Encyclopedia of Genes and GenomesMFMolecular FunctionOSOverall SurvivalqRT-PCRQuantitative Real-Time Polymerase Chain ReactionRFSRelapse Free SurvivalROCReceiver Operating CharacteristicSDHASuccinate Dehydrogenase Complex Flavoprotein Subunit ATCGAThe Cancer Genome AtlasUCSCUniversity of California Santa Cruz